View Post

How 3,500 women helped save my sister’s life

In Clinical Trials by Barbara Jacoby

By: Lindsey Wahlstrom-Edwards Source: antidote.me I have never been one for anniversaries, but life after my sister’s diagnosis with triple positive breast cancer seems to be full of them. December 1st she found a tumor. December 15th we learned it was cancer. December 17th – her 35th birthday – we learned it was HER2+. December 26th – the fourth anniversary …

View Post

All Patients With Metastatic Breast Cancer Should Undergo Germline Testing, Study Finds

In In The News by Barbara Jacoby

By: Laura Joszt From: ajmc.com All patients with metastatic breast cancer should undergo genetic testing, according to a new study on the prevalence of pathogenic/likely pathogenic (P/LP) variants in patients with metastatic breast cancer. The results, published in JAMA Oncology, highlight that there is a high prevalence of P/LP variants among the group of patients with metastatic breast cancer, which could have …

View Post

What Influence Do Treatment Costs Have on Breast Cancer Surgery Preferences?

In In The News by Barbara Jacoby

By: Christina Bennett, MS From: cancernetwork.com When deciding about surgery for breast cancer, women, especially those with a lower household income, factored cost of treatment into their decision, according to a study reported in the Journal of Oncology Practice. Julie Nangia, MD, an assistant professor of medicine at the Lester and Sue Breast Center at Baylor College of Medicine, Houston, …

View Post

Proton Radiotherapy Safe, Effective for Nonmetastatic Breast Cancer

In Clinical Trials by Barbara Jacoby

From: oncnet.com Proton radiotherapy is an effective and safe alternative to conventional radiotherapy, according to results from a phase 2 study of patients with nonmetastatic breast cancer (J Clin Oncol. 2019 Aug 26. Epub ahead of print). Rachel Jiminez, MD, Massachusetts General Hospital, Boston, MA, and colleagues, conducted the phase 2 study with aims to evaluate the safety and efficacy of …

View Post

Fewer lymph node operations for breast cancer patients with new prediction models

In In The News by Barbara Jacoby

By: Lund University From: medicalxpress.com In recently published studies, researchers at Lund University and Skåne University Hospital in Sweden have produced new prediction models for improved personalized treatment of lymph nodes in breast cancer patients. The latest results that have now been published in Clinical Cancer Research and BMC Cancer show that up to one in every three operations could …

View Post

20% of women getting lumpectomies need a second surgery, but this risk can be lowered

In In The News by Barbara Jacoby

By: Sheldon Feldman, M.D., F.A.C.S. From: sharsheret.org The lumpectomy procedure (sometimes referred to as Breast Conserving Surgery, or BCS) is the treatment of choice for many people with early-stage breast cancer. The surgeon seeks to remove the malignant tumor, while leaving behind as much healthy breast tissue as possible.   Studies show that this procedure, when coupled with radiation, is …

View Post

Context Therapeutics and SOLTI launch ONAWA: a Window of Opportunity Study in Breast Cancer with Apristor

In Clinical Trials by Barbara Jacoby

Source: Business Wire From: manchestertimes.com Context Therapeutics, a clinical-stage biopharmaceutical company dedicated to advancing medicines for hormone driven cancers, today announced a clinical collaboration with SOLTI, a leading collaborative and academic group in Spain dedicated to clinical and translational research in breast cancer. This clinical collaboration, being supported by Context and sponsored by SOLTI, is a window of opportunity study …

View Post

New SU2C teams accelerate clinical trials for difficult breast & prostate cancers

In Clinical Trials by Barbara Jacoby

Source: Stand Up To Cancer From: eurekalert.org Stand Up To Cancer (SU2C) is launching teams of experts to lead innovative attacks on two types of cancer that have defied conventional treatment: triple-negative breast cancer (TNBC) in women and metastatic prostate cancer in men. The $6 million effort supported by SU2C Catalyst Founding Collaborator, Genentech, a member of the Roche Group, …

View Post

Cancer cells turn to cannibalism to survive chemotherapy, study suggests

In In The News by Barbara Jacoby

By: Rockefeller University Press From: medicalxpress.com Researchers from the Tulane University School of Medicine have discovered that some cancer cells survive chemotherapy by eating their neighboring tumor cells. The study, which will be published September 17 in the Journal of Cell Biology, suggests that this act of cannibalism provides these cancer cells with the energy they need to stay alive …